deltatrials
Completed PHASE2 INTERVENTIONAL 1-arm NCT02513498

Ixazomib Citrate in Treating Patients With Chronic Graft-versus-Host Disease

Ixazomib for Treatment of Chronic Graft vs. Host Disease

Sponsor: Fred Hutchinson Cancer Center

Conditions Chronic Graft Versus Host Disease
Interventions Ixazomib Citrate Laboratory Biomarker Analysis Quality-of-Life Assessment Questionnaire Administration
Updated 13 times since 2017 Last updated: Jan 15, 2019 Started: Dec 8, 2015 Primary completion: Jan 5, 2018 Completion: Jun 27, 2018
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT02513498, this PHASE2 trial focuses on Chronic Graft Versus Host Disease and remains completed. Sponsored by Fred Hutchinson Cancer Center, it has been updated 13 times since 2015, reflecting substantial change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

~Jan 2017 – ~Feb 2017 · 31 days · monthly snapshot~Feb 2017 – ~Oct 2017 · 8 months · monthly snapshot~Oct 2017 – ~Jun 2018 · 8 months · monthly snapshot~Jun 2018 – ~Nov 2018 · 5 months · monthly snapshot~Nov 2018 – ~Mar 2019 · 4 months · monthly snapshot~Mar 2019 – ~Jan 2021 · 22 months · monthly snapshot~Jan 2021 – ~May 2022 · 16 months · monthly snapshot~May 2022 – ~Dec 2022 · 7 months · monthly snapshot~Dec 2022 – ~Jan 2023 · 31 days · monthly snapshot~Jan 2023 – ~Jul 2024 · 18 months · monthly snapshot~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshot~Sep 2024 – ~Sep 2025 · 12 months · monthly snapshot~Sep 2025 – present · 12 months · monthly snapshot

Change History

13 versions recorded

  1. Sep 2025 — Present [monthly]

    Completed PHASE2

  2. Sep 2024 — Sep 2025 [monthly]

    Completed PHASE2

  3. Jul 2024 — Sep 2024 [monthly]

    Completed PHASE2

  4. Jan 2023 — Jul 2024 [monthly]

    Completed PHASE2

  5. Dec 2022 — Jan 2023 [monthly]

    Completed PHASE2

▶ Show 8 earlier versions

  1. May 2022 — Dec 2022 [monthly]

    Completed PHASE2

  2. Jan 2021 — May 2022 [monthly]

    Completed PHASE2

  3. Mar 2019 — Jan 2021 [monthly]

    Completed PHASE2

  4. Nov 2018 — Mar 2019 [monthly]

    Completed PHASE2

    Status: Active Not Recruiting → Completed

  5. Jun 2018 — Nov 2018 [monthly]

    Active Not Recruiting PHASE2

  6. Oct 2017 — Jun 2018 [monthly]

    Active Not Recruiting PHASE2

    Status: Recruiting → Active Not Recruiting

  7. Feb 2017 — Oct 2017 [monthly]

    Recruiting PHASE2

  8. Jan 2017 — Feb 2017 [monthly]

    Recruiting PHASE2

    First recorded

Dec 2015

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Fred Hutchinson Cancer Center
  • National Cancer Institute (NCI)
Data source: Fred Hutchinson Cancer Center

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations